Clinical trial NCT06606665: Balance, Cognıtıve Skılls, Hand Functıons and Qualıty of Lıfe Among Patients with Bronchiectasis and Healthy Peers
Official title: Comparıson of Balance, Cognıtıve Skılls, Hand Functıons and Qualıty of Lıfe Between Elderly Patıents Wıth Bronchiectasis and Healthy Peers
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Bronchiectasis
Keywords: bronchiectasis
elderly
balance
cognitive ability
hand grip strength
hand functions
quality of life
lower extremity muscle strength
respiratory function parameters
reaction time
Lead sponsor: Atlas University
Sponsor class: OTHER
First posted: 2024-09-23
Enrollment: 30
Sex: ALL
Minimum age (years): 65
Maximum age (years): 90
Standard ages: OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Elderly with diagnosed with bronchiectasis and age matched healthy volunteers who do not have any diagnosed chronic diseases.

Brief summary: The aim of this study is to comparatively evaluate the parameters of balance, cognitive skills, hand grip strength, reaction time, quality of life and respiratory functions in elderly and healthy peers individuals.

Detailed description: Deterioration of airway patency, respiratory functions, experiencing shortness of breath that limits functional capacity, impairments in health-related quality of life, balance, cognitive skills, hand grip strength and reaction time parameters make physiotherapy approaches important in the treatment of bronchiectasis.

Eligibility criteria: Inclusion Criteria:

* Clinically diagnosed with bronchiectasis and in stable condition,
* No known systemic, orthopedic or neurological disease,
* Can walk,
* Volunteer for research,
* Able to cooperate,
* Elderly individuals aged 65 and over with bronchiectasis
* Healthy elderly individuals aged 65 and over

Exclusion Criteria:

* Individuals under 65 years of age
* Individuals with FEV1 values \< 40%
* History of uncontrolled hypertension, arrhythmia and MI in the last month
* Having a history of lung or liver transplantation,
* Unstable angina,
* Those with serious cardiac problems such as advanced heart failure,
* Hemodynamically unstable cases,
* Those who have used antibiotics in the last three weeks,
* Those with acute exacerbation
* Those with insufficient awareness and cooperation,
* Those with pregnancy and malignancy,
* Those who have orthopedic or surgical problems that may prevent tests,
* Those who did not agree to participate in the research

Primary outcomes:
measure: Wii Fit Balance Board
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
Secondary outcomes:
measure: Montreal Cognitive Assessment Scale.
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
measure: APP- Coo-Test
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
measure: Nottingham Health Profile (NIH)
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
measure: 30 Second Sit and Stand Test
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
measure: Hand Grip Force Test
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
measure: Pulmonary Function Test
timeFrame: The assessment will be administered only once to each participant. All tests will be performed on the same day and will take approximately 30 minutes.
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul Atlas University
state: KAgıthane
Study officials:
References: